Glaukos Corporation has grown revenue 27% a year over three years and 17% a year over five. Revenue growth, 3-year annual rate: +27% (Medical Devices median +12%). Revenue growth, 5-year rate: +17%, growth has picked up over the last three years. Years of annual history on file: 13, FY2013 to FY2025, as filed.

GKOSGlaukos Corporation

Healthcare

$165.63+98% 1Y

$165.63

$74.6752 weeks$189.58

Is it growing?

Mixed

Neither accelerating nor breaking down: revenue growing +42% year on year, but operating margin narrowing (−10.5 points).

1 good, 1 to watch, 1 without data

Revenue trend+42% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +17% a year.

Margin direction−10.5 points operating

Trailing-twelve-month operating margin, -33.1% now against -22.6% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is GKOS growing?

Glaukos Corporation has grown revenue 27% a year over three years and 17% a year over five.

+27%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +17%
Revenue growth, 5-year rate · +27% over three · growth has picked up over the last three years
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed

Details›